loading page

DO SEVERE PEDIATRIC ASTHMA PATIENTS HAVE AN INCREASED SUSCEPTIBILITY OF BEING INFECTED BY COVID-19?
  • +5
  • Roxana Farzanegan,
  • Natalia Molini-Menchón,
  • Antonio Michavila,
  • Jose Vicente Castelló Carrascosa,
  • María Cruz Torres Gorriz,
  • Raquel Cervera Aznar,
  • Julián Borrás Cuartero,
  • Ernesto Enrique Miranda
Roxana Farzanegan
Hospital General Universitari de Castelló
Author Profile
Natalia Molini-Menchón
Hospital General Universitari de Castelló
Author Profile
Antonio Michavila
Hospital General Universitari de Castello
Author Profile
Jose Vicente Castelló Carrascosa
Hospital General Universitari de Castelló
Author Profile
María Cruz Torres Gorriz
Hospital General Universitari de Castelló
Author Profile
Raquel Cervera Aznar
Hospital General Universitari de Castelló
Author Profile
Julián Borrás Cuartero
Hospital General Universitari de Castelló
Author Profile
Ernesto Enrique Miranda
Hospital General Universitari de Castelló
Author Profile

Abstract

Background: The Coronavirus disease 2019 caused by SARS-CoV2 virus has rapidly spread worldwide becoming one of the most important challenges humans are facing nowadays. Risk factors for severe outcomes have been identified, but asthma seems not to be one of them. Objectives: To analyze lifestyle before the pandemic in severe pediatric asthma patients in treatment with a monoclonal antibody, belonging to Castellon’s Universitary General Hospital Health’s Department, and investigate the prevalence of COVID-19 in these patients in order to see if their lifestyle may have influenced the probability of being infected by COVID-19. Methods: A questionnaire was developed asking about: their lifestyle before the pandemic; suggestive COVID-19 symptoms and exposition to the disease; and patients’ behavior, asthma control and treatment during the pandemic. Total SARS-Cov-2 antibody tests were performed to all patients. Results: A total of 15 patients were included. All patients had a high social exposure before the pandemic. 2 patients had direct contact with positive COVID-19 patients. Both experienced mild symptoms that could be attributed to the disease, but neither of them had a positive serological test. Most patients followed asthma treatment correctly before and during the pandemic. 13 patients referred good asthma control. Most patients continued monthly monoclonal antibody administration. Serological tests were negative for all patients. Conclusion: Severe asthma pediatric patients in treatment with MAB, do not have an increased susceptibility for being infected by the virus, but in the case that they contracted the disease, evidence says they would have shown very weak symptoms.